Artiva Biotherapeutics
Mallory Paynich Murray started their work experience in 2017 at the La Jolla Institute for Immunology, where they served as a Postdoctoral Research Fellow until April 2022. In April 2022, they joined Artiva Biotherapeutics as a Scientist II.
Mallory Paynich Murray pursued their education by completing a Bachelor of Science degree in Biochemistry and Molecular Biology from Michigan State University, spanning from 2004 to 2008. Following this, they pursued their Doctor of Philosophy degree in Microbiology and Immunology from Loyola University Chicago, commencing in 2010 and concluding in 2016.
Artiva Biotherapeutics
1 followers
Artiva Biotherapeutics is advancing NK cell therapy and CAR-NK therapy for cancer, including blood cancers and solid tumors.